1. Home
  2. OLMA vs LND Comparison

OLMA vs LND Comparison

Compare OLMA & LND Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • OLMA
  • LND
  • Stock Information
  • Founded
  • OLMA 2006
  • LND 2005
  • Country
  • OLMA United States
  • LND Brazil
  • Employees
  • OLMA N/A
  • LND N/A
  • Industry
  • OLMA Biotechnology: Pharmaceutical Preparations
  • LND Farming/Seeds/Milling
  • Sector
  • OLMA Health Care
  • LND Consumer Staples
  • Exchange
  • OLMA Nasdaq
  • LND Nasdaq
  • Market Cap
  • OLMA 378.9M
  • LND 376.5M
  • IPO Year
  • OLMA 2020
  • LND 2006
  • Fundamental
  • Price
  • OLMA $7.75
  • LND $3.93
  • Analyst Decision
  • OLMA Strong Buy
  • LND
  • Analyst Count
  • OLMA 5
  • LND 0
  • Target Price
  • OLMA $24.00
  • LND N/A
  • AVG Volume (30 Days)
  • OLMA 1.1M
  • LND 31.8K
  • Earning Date
  • OLMA 11-11-2025
  • LND 11-05-2025
  • Dividend Yield
  • OLMA N/A
  • LND 6.32%
  • EPS Growth
  • OLMA N/A
  • LND N/A
  • EPS
  • OLMA N/A
  • LND 0.25
  • Revenue
  • OLMA N/A
  • LND $194,084,753.00
  • Revenue This Year
  • OLMA N/A
  • LND $40.80
  • Revenue Next Year
  • OLMA N/A
  • LND $5.24
  • P/E Ratio
  • OLMA N/A
  • LND $15.28
  • Revenue Growth
  • OLMA N/A
  • LND 3.73
  • 52 Week Low
  • OLMA $2.86
  • LND $3.49
  • 52 Week High
  • OLMA $13.93
  • LND $4.97
  • Technical
  • Relative Strength Index (RSI)
  • OLMA 64.67
  • LND 55.65
  • Support Level
  • OLMA $7.49
  • LND $3.78
  • Resistance Level
  • OLMA $8.40
  • LND $3.96
  • Average True Range (ATR)
  • OLMA 0.67
  • LND 0.10
  • MACD
  • OLMA 0.08
  • LND -0.00
  • Stochastic Oscillator
  • OLMA 75.63
  • LND 62.50

About OLMA Olema Pharmaceuticals Inc.

Olema Pharmaceuticals inc is a clinical-stage biopharmaceutical company. It is focused on the discovery, development, and commercialization of next generation targeted therapies for women's cancers. Its therapies offer the potential to improve outcomes for women living with cancer. The company has completed discovery and preclinical studies of OP-1250. OP-3136 is another drug candidate in the company's product pipeline.

About LND Brasilagro Brazilian Agric Real Estate Co Sponsored ADR (Brazil)

Brasilagro - Cia Bras de Prop Agricolas is a Brazil-based company, engaged in the acquisition, development, operation, and sale of rural properties suitable for agricultural activities. The business activity of the firm is operated through Real estate, Grains, Sugarcane, Cattle rising, Cotton, and Other segments. The Grains segment is involved in the production and sale of soybean and corn. The Sugarcane segment includes the sale of raw product. The Real Estate segment presents the P&L from operations carried out in the company's subsidiaries. The Cattle Raising segment consists of producing and selling beef calves after weaning, which characterizes the activity as breeding and the Other segment engages in other corporate activities. The majority of revenue is earned from Grain Segment.

Share on Social Networks: